Ilant Health has secured $15 million in Series A funding, led by Cornucopian Capital with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, and existing investors. This capital infusion brings the company's total funding to over $22 million. The funds will be used to scale its value-based obesity treatment platform, which partners with employers and health plans to improve clinical outcomes and lower healthcare costs.